Identification of HOXD10 as a Marker of Poor Prognosis in Glioblastoma Multiforme.

Yanxin LiKe MaQi XieXianwei ZhangXiulei Zhang Kui ChenLingfei KongRongjun Qian

Published in: OncoTargets and therapy (2021)

Based on our experimental data, although HOXD10 expression is low in GBM compared with normal brain tissue, GBM patients with high HOXD10 expression have a worse prognosis. HOXD10 may play different or even opposite roles in different stages of GBM occurrence and development. For patients with GBM, HOXD10 may be a valid predictor of prognosis.

Keyphrases

poor prognosis
long non coding rna
risk assessment
big data
white matter
machine learning
resting state
binding protein
artificial intelligence
functional connectivity